Site
Duke Cancer Institute (Durham, NC)
USA in_activation KRI unscoredPrincipal investigator Dr. Okafor
Patients
0
Active
0
enrolled or consented
Withdrawn
0
Serious AEs
0
Open QA findings
0
Aged data queries
0
Studies & contracts
total budget 45000.00 USD
A Phase 1 Study to Evaluate Intratumoral Doxorubicin Exposure Following Administration of Aldoxorubicin or Doxorubicin
Phase I
study startup
contract pending
45000 USD
Patients first 0
| Ref | Status | Consented | Study |
|---|---|---|---|
|
No patients at this site Enrolment happens through the study's matching step. |
|||
Luna participants 0
Safety
0 AEs · 0 serious
No serious adverse events at this site
Non-serious events are listed under Data & Safety.
QA findings
0 open
No findings recorded
Findings are filed by monitoring visits.
Monitoring visits 0
No visits recorded
Re-score risk to propose an on-site visit.
Payments 0
No payments on file
Milestone payments are proposed by the finance step and approved in the review queue.